US 11,654,136 B2
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Xiong Cai, Bedford, MA (US); Haixiao Zhai, Bedford, MA (US); Chengjung Lai, Belmont, MA (US); Changgeng Qian, Wayland, MA (US); and Rudi Bao, Wellesley, MA (US)
Assigned to Curis, Inc., Lexington, MA (US)
Filed by Curis, Inc., Lexington, MA (US)
Filed on Sep. 9, 2021, as Appl. No. 17/470,410.
Application 17/470,410 is a continuation of application No. 16/736,081, filed on Jan. 7, 2020, granted, now 11,135,205.
Application 16/736,081 is a continuation of application No. 16/150,845, filed on Oct. 3, 2018, granted, now 10,543,197, issued on Jan. 28, 2020.
Application 16/150,845 is a continuation of application No. 15/496,318, filed on Apr. 25, 2017, granted, now 10,111,864, issued on Oct. 30, 2018.
Application 15/496,318 is a continuation of application No. 14/979,887, filed on Dec. 28, 2015, granted, now 9,657,032, issued on May 23, 2017.
Application 14/979,887 is a continuation of application No. 14/197,769, filed on Mar. 5, 2014, granted, now 9,249,156, issued on Feb. 2, 2016.
Application 14/197,769 is a continuation of application No. 13/435,062, filed on Mar. 30, 2012, granted, now 8,710,219, issued on Apr. 29, 2014.
Claims priority of provisional application 61/559,489, filed on Nov. 14, 2011.
Claims priority of provisional application 61/470,849, filed on Apr. 1, 2011.
Prior Publication US 2022/0168284 A1, Jun. 2, 2022
Int. Cl. A61K 31/4365 (2006.01); C07D 495/04 (2006.01); A61K 31/166 (2006.01); C07D 213/30 (2006.01); C07D 241/10 (2006.01)
CPC A61K 31/4365 (2013.01) [A61K 31/166 (2013.01); C07D 213/30 (2013.01); C07D 241/10 (2013.01); C07D 495/04 (2013.01)] 12 Claims
 
1. A salt of a compound represented by the formula:

OG Complex Work Unit Chemistry
wherein said salt is a sodium salt, a potassium salt, a choline salt, or a sulfate salt.